Skip to main content
main-content

Zeitschrift

Medical Oncology

Medical Oncology 3/2012

Ausgabe 3/2012

Inhaltsverzeichnis ( 133 Artikel )

01.09.2012 | Case Report | Ausgabe 3/2012

Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland

Douglas F. Beach, William J. Klump, Ghada Haddad, Lisa M. Reid, Roland Schwarting, Alexandre Hageboutros

01.09.2012 | Original Paper | Ausgabe 3/2012

ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study

Qiu-li Li, Fu-jin Chen, Renchun Lai, Zhu-ming Guo, Rongzhen Luo, An-kui Yang

01.09.2012 | Case Report | Ausgabe 3/2012

A previously unreported malignancy of the thyroid

Bulent Cetin, Suleyman Buyukberber, Senem Senturk, Omer Uluoglu, Ugur Coskun, Mustafa Benekli

01.09.2012 | Original Paper | Ausgabe 3/2012

GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma

Jean-Philippe Spano, Y. Vano, S. Vignot, T. De La Motte Rouge, L. Hassani, R. Mouawad, F. Menegaux, D. Khayat, L. Leenhardt

01.09.2012 | Original Paper | Ausgabe 3/2012

Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis

Yong Li, Liang Li, Jing Ting Wang, Xuan Kan, Jian Guang Lu

01.09.2012 | Original Paper | Ausgabe 3/2012

Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma

M. Grimm, M. Lazariotou

01.09.2012 | Original Paper | Ausgabe 3/2012

The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy

Yanqin Yang, Jize Xuan, Zhiqiang Yang, Anqin Han, Ligang Xing, Jinbo Yue, Man Hu, Jinming Yu

01.09.2012 | Original Paper | Ausgabe 3/2012

Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes

Yanhong Zhou, Wei Wang, Danwei Zheng, Shuping Peng, Wei Xiong, Jian Ma, Zhaoyang Zeng, Minghua Wu, Ming Zhou, Juanjuan Xiang, Bo Xiang, Xiaoling Li, Xiayu Li, Guiyuan Li

01.09.2012 | Review Article | Ausgabe 3/2012

Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer

Alexandros Georgolios, Anna Eleftheriadou, Anna Batistatou, Kostandinos Charalabopoulos

01.09.2012 | Original Paper | Ausgabe 3/2012

Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR4 and of uPA system

Henriqueta Coimbra Silva, Vera Alves, Luis Alcides Mesquita Nogueira, Manuel Santos Rosa, Lina Carvalho, Fernando Regateiro

01.09.2012 | Letter to the Editor | Ausgabe 3/2012

Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission

Michael Mark, Beat Thürlimann

01.09.2012 | Original Paper | Ausgabe 3/2012

CD44+/CD24− cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast

Daniel Guimarães Tiezzi, Fernando Antonio Mourão Valejo, Heitor Ricardo Cosinski Marana, Hélio Humberto Angotti Carrara, Luciana Benevides, Heriton Marcelo Ribeiro Antonio, Renata Danielle Sicchieri, Cristiane Maria Milanezi, João Santana da Silva, Jurandyr Moreira de Andrade

01.09.2012 | Original Paper | Ausgabe 3/2012

Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling

D. Kostyal, R. S. Welt, J. Danko, T. Shay, C. Lanning, K. Horton, S. Welt

01.09.2012 | Original Paper | Ausgabe 3/2012

Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis

Nuttapong Ngamphaiboon, Tracey L. O’Connor, Pooja P. Advani, Ellis G. Levine, Ellen B. Kossoff

01.09.2012 | Original Paper | Ausgabe 3/2012

Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients

Mahdieh Salimi, Hossein Mozdarani, Keivan Majidzadeh

01.09.2012 | Review Article | Ausgabe 3/2012

Leptin and breast cancer: an overview

Mehmet Artac, Kadri Altundag

01.09.2012 | Short Communication | Ausgabe 3/2012

Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population

Lisbeth Herrera-Romano, Nora Fernández-Tamayo, Eduardo Gómez-Conde, Juan M. Reyes-Cardoso, Felipe Ortiz-Gutierrez, Guillermo Ceballos, Alejandra Valdivia, Patricia Piña, Mauricio Salcedo

01.09.2012 | Original Paper | Ausgabe 3/2012

Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers

Guzin Gonullu Demirag, Yurdanur Sullu, Idris Yucel

01.09.2012 | Original Paper | Ausgabe 3/2012

Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer

Steve R. Martinez, Warren H. Tseng, Dhruvil R. Shah, Robert J. Canter, Richard J. Bold

01.09.2012 | Original Paper | Ausgabe 3/2012

Genetic alterations of the WWOX gene in breast cancer

Seda Ekizoglu, Mahmut Muslumanoglu, Nejat Dalay, Nur Buyru

01.09.2012 | Original Paper | Ausgabe 3/2012

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer

H. Wong, S. Lau, R. Leung, J. Chiu, P. Cheung, T. T. Wong, R. Liang, R. J. Epstein, T. Yau

01.09.2012 | Original Paper | Ausgabe 3/2012

Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients

Xuefeng Bai, Feng Jin, Yingzi Fu, Zhaojin Yu, Lin Zhao, Jie Ren, Yanlin Li, Xuyang Jiao, Haishan Zhao, Weifan Yao, Xiaoyi Mi, Enhua Wang, Olufunmilayo I. Olopade, Mingyi Zhou, Minjie Wei

01.09.2012 | Original Paper | Ausgabe 3/2012

Girdin protein: a new potential distant metastasis predictor of breast cancer

Caigang Liu, Yanjun Zhang, Hong Xu, Ruishan Zhang, Hua Li, Ping Lu, Feng Jin

01.09.2012 | Original Paper | Ausgabe 3/2012

Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese

Da Pang, Yashuang Zhao, Weinan Xue, Ming Shan, Yanbo Chen, Youxue Zhang, Guoqiang Zhang, Feng Liu, Dalin Li, Yanmei Yang

01.09.2012 | Original Paper | Ausgabe 3/2012

Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women

Lin Zhao, Zhaojin Yu, Yunan Li, Xiaoyan Wen, Wenfeng Ma, Lin Wang, Jie Ren, Caigang Liu, Miao He, Xuefeng Bai, Mingli Sun, Zhihong Zheng, Xiaoyi Mi, Enhua Wang, Olufunmilayo I. Olopade, Feng Jin, Minjie Wei

01.09.2012 | Original Paper | Ausgabe 3/2012

Type 2 diabetes mellitus and prognosis in early stage breast cancer women

Muhammet Ali Kaplan, Zafer Pekkolay, Mehmet Kucukoner, Ali İnal, Zuhat Urakci, Hamza Ertugrul, Recai Akdogan, Ugur Firat, İsmail Yildiz, Abdurrahman Isikdogan

01.09.2012 | Original Paper | Ausgabe 3/2012

GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility

Mahboobe Miri, Simin Hemati, Foruzan Safari, Manoochehr Tavassoli

01.09.2012 | Original Paper | Ausgabe 3/2012

High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer

Badovinac Črnjević Tanja, Spagnoli Giulio, Juretić Antonio, Jakić-Razumović Jasminka, Podolski Paula, Šarić Nera

01.09.2012 | Erratum | Ausgabe 3/2012

Erratum to: High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer

Tanja Badovinac-Črnjević, Giulio Spagnoli, Antonio Juretić, Jasminka Jakić-Razumović, Paula Podolski, Nera Šarić

01.09.2012 | Original Paper | Ausgabe 3/2012

Gender differences in lung cancer mortality trends in Andalusia 1975–2008: a joinpoint regression analysis

Aurelio Cayuela, Susana Rodríguez-Domínguez, Luis Jara-Palomares, Remedios Otero-Candelera, Jose Luis López-Campos, Eduardo Vigil

01.09.2012 | Review Article | Ausgabe 3/2012

Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer

Alfredo Tartarone, Rose Lerose, Giuseppina Gallucci, Raffaele Ardito, Michele Aieta

01.09.2012 | Original Paper | Ausgabe 3/2012

The relationship between Bmi-1 and the epithelial–mesenchymal transition in lung squamous cell carcinoma

Jun Huang, Yuan Qiu, Guoqin Chen, Liyan Huang, Jianxing He

01.09.2012 | Original Paper | Ausgabe 3/2012

Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib

Katsuhiro Masago, Yosuke Togashi, Shiro Fujita, Yuichi Sakamori, Chiyuki Okuda, Young Hak Kim, Tadashi Mio, Michiaki Mishima

01.09.2012 | Original Paper | Ausgabe 3/2012

DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy

Dairong Li, Qi Zhou, Yu Liu, Yanqing Yang, Qiying Li

01.09.2012 | Original Paper | Ausgabe 3/2012

Long-term chemotherapy may prolong survival in advanced non-small-cell lung cancer among responders to first-line chemotherapy

Tomonori Hirashima, Hidekazu Suzuki, Masashi Kobayashi, Youko Kondoh, Yoshie Tokuoka, Yuka Matsuura, Motohiro Tamiya, Naoko Morishita, Shinji Sasada, Norio Okamoto, Kohei Akazawa, Ichiro Kawase

01.09.2012 | Original Paper | Ausgabe 3/2012

Combination of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension

Bojan Zaric, Branislav Perin, Heinrich D. Becker, Felix FJ Herth, Ralf Eberhardt, Svetlana Jovanovic, Tihomir Orlic, Milana Panjkovic, Biljana Zvezdin, Aleksandra Jovelic, Milorad Bijelovic, Vladimir Jurisic, Milan Antonic

01.09.2012 | Original Paper | Ausgabe 3/2012

CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis

Peng Xu, Xiao-Lan Xu, Qiang Huang, Zhi-Hong Zhang, Yan-Bei Zhang

01.09.2012 | Original Paper | Ausgabe 3/2012

Loss of Bad expression confers poor prognosis in non-small cell lung cancer

Yi Huang, Dan Liu, Bojiang Chen, Jing Zeng, Lei Wang, Shangfu Zhang, Xianming Mo, Weimin Li

01.09.2012 | Original Paper | Ausgabe 3/2012

Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival

Li Guo, Shu-Ping Bai, Ling Zhao, Xiao-Hong Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma

Kyoichi Kaira, Yasuhisa Ohde, Kazuo Nakagawa, Takehiro Okumura, Haruyasu Murakami, Toshiaki Takahashi, Haruhiko Kondo, Takashi Nakajima, Masahiro Endo, Nobuyuki Yamamoto

01.09.2012 | Original Paper | Ausgabe 3/2012

MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis

Lan-tao Chen, Shi-dong Xu, Hai Xu, Jin-feng Zhang, Jin-feng Ning, Sheng-fa Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

Liang Luo, Ting Zhang, Hongbing Liu, Tangfeng Lv, Dongmei Yuan, Yanwen Yao, Yanling Lv, Yong Song

01.09.2012 | Original Paper | Ausgabe 3/2012

Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study

Li-kun Chen, He Huang, Hai Liao, Guo-zhen Liu, Yin-duo Zeng, Xiao-xiao Dinglin, Guang-chuan Xu, Wei-dong Wei

01.09.2012 | Original Paper | Ausgabe 3/2012

Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer

Hanan Ahmed Wahba, Hend Ahmed El-Hadaad, Ehab Atef Abd-Ellatif

01.09.2012 | Original Paper | Ausgabe 3/2012

Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma

Marco K. C. Hui, Kenneth K. Y. Lai, Kwok Wah Chan, John M. Luk, Nikki P. Lee, Yvonne Chung, Leo C. Cheung, Gopesh Srivastava, Sai Wah Tsao, Johnny C. Tang, Simon Law

01.09.2012 | Short Communication | Ausgabe 3/2012

Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma

Ulas Darda Bayraktar, Soley Bayraktar, Peter Hosein, Emerson Chen, Leonidas G. Koniaris, Caio Max S. Rocha-Lima, Alberto J. Montero

01.09.2012 | Original Paper | Ausgabe 3/2012

Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphoma

Lin Xie, Li-Da Shen, Chen Qing, Zuo-Zhang Yang, Ke Li, Yang Li, Ji-Lan Yang

01.09.2012 | Original Paper | Ausgabe 3/2012

The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis

Jieer Ying, Qi Xu, Gu Zhang, Bixia Liu, Liming Zhu

01.09.2012 | Original Paper | Ausgabe 3/2012

Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population

Yong-ping Mu, Xiu-lan Su

01.09.2012 | Original Paper | Ausgabe 3/2012

Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient

Chengcheng Gao, Liqun Pang, Chengcheng Ren, Tianheng Ma

01.09.2012 | Original Paper | Ausgabe 3/2012

Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer

M. S. Al-Moundhri, I. Al-Hadabi, K. Al-Mawaly, S. Kumar, F. A. R. Al-Lawati, G. Bhatnager, S. Kuruvila, A. Al-Hamdani, S. M. El-Sayed, B. Al-Bahrani

01.09.2012 | Original Paper | Ausgabe 3/2012

Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis

Jian-Feng Zhang, Zhen-Biao Mao, Zeng-Li Li, Shi-Min Xue, Hui-Jun Zhu, Hong Zhang, Run-Zhou Ni

01.09.2012 | Original Paper | Ausgabe 3/2012

An essential role of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors

Lingling Ding, Xia Zhang, Miaoqing Zhao, Zhonghua Qu, Shanying Huang, Mei Dong, Fei Gao

01.09.2012 | Original Paper | Ausgabe 3/2012

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs

J. F. Emile, S. Brahimi, J. M. Coindre, P. P. Bringuier, G. Monges, P. Samb, L. Doucet, I. Hostein, B. Landi, M. P. Buisine, A. Neuville, O. Bouché, P. Cervera, J. L. Pretet, J. Tisserand, A. Gauthier, A. Le Cesne, J. C. Sabourin, J. Y. Scoazec, S. Bonvalot, C. L. Corless, M. C. Heinrich, J. Y. Blay, P. Aegerter

01.09.2012 | Original Paper | Ausgabe 3/2012

Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population

Avishek Kumar, Nihar Shah, Yashpal Modi, Hamid S. Shaaban, Joseph DePasquale, Vincent A. DeBari, Swaroopa Yerrabothala, Michael Maroules, Gunwant K. Guron

01.09.2012 | Original Paper | Ausgabe 3/2012

Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer

Feng Wang, Peng Zhang, Chenzhang Shi, Yongzhi Yang, Huanlong Qin

01.09.2012 | Original Paper | Ausgabe 3/2012

Increased serum level of Nup88 protein is associated with the development of colorectal cancer

Zeng-Ren Zhao, Li-Jing Zhang, Yuan–Yuan Wang, Fang Li, Ming-Wei Wang, Xiao-Feng Sun

01.09.2012 | Review Article | Ausgabe 3/2012

Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome

Kein-Leong Yim

01.09.2012 | Original Paper | Ausgabe 3/2012

The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells

Shuli Xie, Mingguang Zhu, Guoyue Lv, Qiang Zhang, Guangyi Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation

Ming-chun Lai, Zhe Yang, Lin Zhou, Qian-qian Zhu, Hai-yang Xie, Feng Zhang, Li-ming Wu, Lei-ming Chen, Shu-sen Zheng

01.09.2012 | Original Paper | Ausgabe 3/2012

Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection

Kang-jie Chen, Lin Zhou, Hai-yang Xie, Taki-Eldin Ahmed, Xiao-wen Feng, Shu-sen Zheng

01.09.2012 | Original Paper | Ausgabe 3/2012

Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2

Aili Suo, Mingxin Zhang, Yu Yao, Lingmin Zhang, Chen Huang, Kejun Nan, Wanggang Zhang

01.09.2012 | Original Paper | Ausgabe 3/2012

Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China

Lian-Hua Cui, Yang Song, Hongzong Si, Fangzhen Shen, Min-Ho Shin, Hee Nam Kim, Jin-Su Choi

01.09.2012 | Original Paper | Ausgabe 3/2012

Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma

Xiao-Qian Chen, Juan-Ru He, Hui-Yun Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

Zhen-Yu Xiao, Jin-Bin Jia, Lin Chen, Wei Zou, Xiao-Ping Chen

01.09.2012 | Original Paper | Ausgabe 3/2012

miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver

Hong-Yuan Chen, Zhong-Bo Han, Jun-Wei Fan, Jun Xia, Jun-Yi Wu, Guo-Qiang Qiu, Hua-Mei Tang, Zhi-Hai Peng

01.09.2012 | Original Paper | Ausgabe 3/2012

Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome

Sheng-bin Zhang, Shi-peng Song, Bing Li, Yong-sheng Zhou, Yang-de Zhang

01.09.2012 | Original Paper | Ausgabe 3/2012

Clinical value of Tiam1–Rac1 signaling in primary gallbladder carcinoma

Xilin Du, Shengzhi Wang, Jianguo Lu, Qing Wang, Nuan Song, Tao Yang, Rui Dong, Li Zang, Yuan Yang, Tao Wu, Chengguo Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma

Shi-peng Song, Sheng-bin Zhang, Rui Liu, Li Yao, Yu-qin Hao, Ming-mei Liao, Yang-de Zhang, Zhe-hai Li

01.09.2012 | Original Paper | Ausgabe 3/2012

High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker

Ming-Bing Xiao, Feng Jiang, Wen-Kai Ni, Bu-You Chen, Cui-Hua Lu, Xiao-Yan Li, Run-Zhou Ni

01.09.2012 | Original Paper | Ausgabe 3/2012

Frequency of HCV infection in renal cell carcinoma patients

Burçin Budakoğlu, Sercan Aksoy, Çağatay Arslan, Ümmügül Üyetürk, Nalan Akgül Babacan, Muhammet Fuat Özcan, Ramazan Yıldız, Başak Bala Öven, Nuriye Yıldırım Özdemir, Ömer Dizdar, Süleyman Büyükberber, M. Bülent Akıncı, İbrahim Türker, Berna Öksüzoğlu, Kadri Altundag, Nurullah Zengin

01.09.2012 | Review | Ausgabe 3/2012

Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement

C. Porta, G. Tortora, C. Linassier, K. Papazisis, A. Awada, D. Berthold, J. P. Maroto, T. Powles, M. De Santis

01.09.2012 | Original Paper | Ausgabe 3/2012

Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter?

N. Calvani, F. Morelli, S. Leo, L. Orlando, L. Lombardi, A. Gnoni, M. Cinefra, E. Maiello, V. Lorusso, S. Cinieri

01.09.2012 | Letter to the Editor | Ausgabe 3/2012

Sequential therapy in metastatic renal cell carcinoma: what comes next?

Camillo Porta, Thomas Powles

01.09.2012 | Original Paper | Ausgabe 3/2012

Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer

Ivana Vukomanovic, Vidosav Colovic, Ivan Soldatovic, Jovan Hadzi-Djokic

01.09.2012 | Original Paper | Ausgabe 3/2012

Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma

Haifeng Wang, Jiansong Wang, Yigang Zuo, Mingxia Ding, Ruping Yan, Delin Yang, Changxin Ke

01.09.2012 | Original Paper | Ausgabe 3/2012

Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population

Canan Kucukgergin, Oner Sanli, Akın S. Amasyalı, Tzevat Tefik, Sule Seckin

01.09.2012 | Case Report | Ausgabe 3/2012

Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen

A. M. Tatli, M. Uysal, S. S. Goksu, D. Arslan, S. Gunduz, M. Ozdogan, H. S. Coskun, H. Bozcuk, B. Savas

01.09.2012 | Original Paper | Ausgabe 3/2012

The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma

Jian Gang Pan, Xing Zhou, Runqi Luo, Rui Fa Han

01.09.2012 | Review Article | Ausgabe 3/2012

Old issues and new perspectives on prostate cancer hormonal therapy: the molecular substratum

Leonardo Oliveira Reis

01.09.2012 | Review Article | Ausgabe 3/2012

Cytokine and endocrine signaling in prostate cancer

J. Puente Vazquez, E. Grande Pulido, L. M. Anton Aparicio

01.09.2012 | Original Paper | Ausgabe 3/2012

Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China

Xiao Wang, Shuai Wang, Yi-wei Lin, Jian Wu, Hong Chen, Ye-qing Mao, Xiang-yi Zheng, Cheng Zhou, Li-ping Xie

01.09.2012 | Original Paper | Ausgabe 3/2012

Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population

Jia-hong Chen, Hui-chan He, Fu-neng Jiang, Julia Militar, Petor-yang Ran, Guo-qiang Qin, Chao Cai, Xi-bin Chen, Jin Zhao, Zi-yao Mo, Yan-ru Chen, Jian-guo Zhu, Xingyin Liu, Wei-de Zhong

01.09.2012 | Original Paper | Ausgabe 3/2012

The expression of Mcl-1 in human cervical cancer and its clinical significance

Ting Zhang, Chun Zhao, Liang Luo, Hua Zhao, Jing Cheng, Fei Xu

01.09.2012 | Original Paper | Ausgabe 3/2012

Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy

Y. Zhang, S. R. Reng, L. Wang, L. Lu, Z. H. Zhao, Z. K. Zhang, X. D. Feng, X. D. Ding, J. Wang, G. Feng, T. Z. Dai, J. Pu, X. B. Du

01.09.2012 | Original Paper | Ausgabe 3/2012

Overexpression of AQP5 in cervical cancer: correlation with clinicopathological features and prognosis

Ting Zhang, Chun Zhao, Daozhen Chen, Zuomin Zhou

01.09.2012 | Original Paper | Ausgabe 3/2012

Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer

V. Asher, J. Lee, A. Bali

01.09.2012 | Review Article | Ausgabe 3/2012

Leptomeningeal carcinomatosis from ovarian cancer

Eliza Miller, Irene Dy, Thomas Herzog

01.09.2012 | Letter to the Editor | Ausgabe 3/2012

Primary malignant melanoma of the female urethra: 10-year survival

Silvio Altarac, Dino Papeš

01.09.2012 | Case Report | Ausgabe 3/2012

An association between corticosteroid use and melanoma recurrence: a case report and review of the literature

Mark Lazarus, Howard Kaufman

01.09.2012 | Original Paper | Ausgabe 3/2012

Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature

Mutlu Dogan, Bulent Yalcin, Nuriye Yildirim Ozdemir, Ulku Yalcintas Arslan, Lutfi Dogan, Gungor Utkan, Hakan Akbulut, Nurullah Zengin, Necati Alkis, Fikri Icli

01.09.2012 | Original Paper | Ausgabe 3/2012

A preliminary study on the expression of tumor-associated glycoprotein-72 in human gliomas

Dongchun Wang, Yan Zhang, Xiaoli Li, Jianzhong Cui, Shuo Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis

Shiming He, Lianshu Ding, Yizhan Cao, Gang Li, Jianping Deng, Yanyang Tu, Boliang Wang

01.09.2012 | Review Article | Ausgabe 3/2012

Cerebellar glioneuronal tumor: a case report and review of the literature

Ali Mahta, Ewa Borys, Santosh Kesari

01.09.2012 | Original Paper | Ausgabe 3/2012

Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study

Hubert Pan, John Alksne, Arno J. Mundt, Kevin T. Murphy, Mariel Cornell, Santosh Kesari, Joshua D. Lawson

01.09.2012 | Original Paper | Ausgabe 3/2012

Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia

Mina Fathi, Zahra Amirghofran, Mehdi Shahriari

01.09.2012 | Original Paper | Ausgabe 3/2012

Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia

Noha M. EL-Khodary, Sahar M. EL-Haggar, Manal A. Eid, Emad N. Ebeid

01.09.2012 | Original Paper | Ausgabe 3/2012

Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia

Maha Atfy, Mohamad Eissa, Hossam E. Salah, Deena A. El Shabrawy

01.09.2012 | Original Paper | Ausgabe 3/2012

Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results

Maciej Machaczka, Björn Engelbrekt Wahlin, Beata Piatkowska-Jakubas, Malgorzata Rucinska, Wojciech Jurczak, Agnieszka Balana-Nowak, Monika Klimkowska, Hans Hägglund, Aleksander B. Skotnicki

01.09.2012 | Original Paper | Ausgabe 3/2012

Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia

Irena Djunic, Marijana Virijevic, Vladislava Djurasinovic, Aleksandra Novkovic, Natasa Colovic, Nada Kraguljac-Kurtovic, Ana Vidovic, Nada Suvajdzic-Vukovic, Dragica Tomin

01.09.2012 | Short Communication | Ausgabe 3/2012

Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML

Ana Rosa S. Costa, Sintia I. Belangero, Maria Isabel Melaragno, Maria de Lourdes Chauffaille

01.09.2012 | Original Paper | Ausgabe 3/2012

The early addition of arsenic trioxide versus high-dose arabinoside is more effective and safe as consolidation chemotherapy for risk-tailored patients with acute promyelocytic leukemia: multicenter experience

Bin-Tao Huang, Qing-Chun Zeng, Arati Gurung, Wei-Hong Zhao, Zhen Xiao, Bing-Sheng Li

01.09.2012 | Original Paper | Ausgabe 3/2012

Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)

Peter H. Wiernik, Zhuoxin Sun, Holly Gundacker, Gordon Dewald, Marilyn L. Slovak, Elisabeth Paietta, Haesook T. Kim, Frederick R. Appelbaum, Peter A. Cassileth, Martin S. Tallman

01.09.2012 | Original Paper | Ausgabe 3/2012

Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide

Min Xu, Lei Fan, Kou-Rong Miao, Peng Liu, Wei Xu, Jian-Yong Li

01.09.2012 | Original Paper | Ausgabe 3/2012

Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment

Jolanta D. Żołnierczyk, Oxana Komina, Jerzy Z. Błoński, Arleta Borowiak, Barbara Cebula-Obrzut, Piotr Smolewski, Paweł Robak, Zofia M. Kiliańska, Józefa Węsierska-Gądek

01.09.2012 | Original Paper | Ausgabe 3/2012

Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia

Fang Zheng, Huiyu Li, Kaiwei Liang, Yimei Du, Dongmei Guo, Shiang Huang

01.09.2012 | Original Paper | Ausgabe 3/2012

Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia

Nóra Meggyesi, Lajos Kalmár, Sándor Fekete, Tamás Masszi, Attila Tordai, Hajnalka Andrikovics

01.09.2012 | Short Communication | Ausgabe 3/2012

Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma

Maria Kowalska, Joanna Tajer, Magdalena Chechlinska, Malgorzata Fuksiewicz, Beata Kotowicz, Janina Kaminska, Jan Walewski

01.09.2012 | Short Communication | Ausgabe 3/2012

Matrix metalloproteinase-9 is consistently expressed in Hodgkin/Reed-Sternberg cells and has no impact on survival in patients with Epstein–Barr virus (EBV)-related and non-related Hodgkin lymphoma in Brazil

Eni M. Souza, Otávio C. G. Baiocchi, Maria A. Zanichelli, Antonio C. Alves, Marianne G. Assis, Joyce M. K. Silva, Cristine Dobo, José S. R. Oliveira

01.09.2012 | Original Paper | Ausgabe 3/2012

Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy

Liang Wang, Panpan Liu, Xiaoqin Chen, Qirong Geng, Yue Lu

01.09.2012 | Review Article | Ausgabe 3/2012

Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity

Semra Paydas

01.09.2012 | Original Paper | Ausgabe 3/2012

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage

Hua-Jie Dong, Li-Tao Zhou, Cheng Fang, Lei Fan, Dan-Xia Zhu, Yin-Hua Wang, Jian-Yong Li, Wei Xu

01.09.2012 | Letter to the Editor | Ausgabe 3/2012

Mantle cell lymphoma successfully treated in a patient with multiple endocrine neoplasia type 2: a rare combination of two malignancies

Maciej Machaczka

01.09.2012 | Original Paper | Ausgabe 3/2012

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients

Peng-Peng Xu, Yan Wang, Yang Shen, Li Wang, Zhi-Xiang Shen, Wei-Li Zhao

01.09.2012 | Original Paper | Ausgabe 3/2012

A novel prognostic model for extranodal natural killer/T-cell lymphoma

Jia-Jia Huang, Ying-Jie Zhu, Yi Xia, Wei Zhao, Tong-Yu Lin, Wen-Qi Jiang, Hui-Qiang Huang, Zhi-Ming Li

01.09.2012 | Original Paper | Ausgabe 3/2012

Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery

J. S. Ungerstedt, E. Watz, K. Uttervall, B-M Johansson, B. E. Wahlin, P. Näsman, P. Ljungman, A. Gruber, U. Axdorph Nygell, H. Nahi

01.09.2012 | Original Paper | Ausgabe 3/2012

Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma

Xiao Gao, Chunming Li, Run Zhang, Ruifang Yang, Xiaoyan Qu, Hairong Qiu, Jiaren Xu, Hua Lu, Jianyong Li, Lijuan Chen

01.09.2012 | Original Paper | Ausgabe 3/2012

Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases

Nada Suvajdzic, Predrag Djurdjevic, Milena Todorovic, Maja Perunicic, Roksanda Stojanović, Aleksandra Novkovic, Biljana Mihaljevic

01.09.2012 | Original Paper | Ausgabe 3/2012

Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study

Milena Todorovic, Bela Balint, Bosko Andjelic, Dejana Stanisavljevic, Nada Kraguljac Kurtovic, Ziv Radisavljevic, Biljana Mihaljevic

01.09.2012 | Letter to the Editor | Ausgabe 3/2012

Letter to the editor regarding the article by Uzunoglu et al

Yasemin Savranlar, Mehmet Fatih Sönmez

01.09.2012 | Original Paper | Ausgabe 3/2012

Association of clinical and pathological variables with survival in thymoma

Adnan Aydiner, Alper Toker, Fatma Sen, Ercan Bicakci, Esra Kaytan Saglam, Suat Erus, Yesim Eralp, Faruk Tas, Ethem Nezih Oral, Erkan Topuz, Sukru Dilege

01.09.2012 | Original Paper | Ausgabe 3/2012

Evaluation of pirarubicin–cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute

Wei-Xiang Qi, Ai-Na He, Li-Na Tang, Zan Shen, Yang Yao

01.09.2012 | Original Paper | Ausgabe 3/2012

Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma

Chao Zeng, Zun-Fu Ke, Zheng Yang, Zhuo Wang, Shi-Cong Yang, Can-Qiao Luo, Lian-Tang Wang

01.09.2012 | Original Paper | Ausgabe 3/2012

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

Beatriz Pardo, Ramón Salazar, Eva Ciruelos, Hernán Cortés-Funes, Margarita García, Margarita Majem, Ana Montes, Carmen Cuadra, Arturo Soto-Matos, Claudia Lebedinsky, Vicente Alfaro, Luis Paz-Ares

01.09.2012 | Original Paper | Ausgabe 3/2012

Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production

ShiHai Zhang, Jing Zhou, CuiLing Zhang, HuiWen Wu, Yi Wang, JianMin Bian, Jun Guo, XiangYang Wu

01.09.2012 | Original Paper | Ausgabe 3/2012

Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine

Aili He, Wanggang Zhang, KangLing Xu, Jianli Wang, Yun Yang, Xingmei Chao

01.09.2012 | Original Paper | Ausgabe 3/2012

Comparative study of the immunohistochemical expression of tissue inhibitors of metalloproteinases 1 and 2 between clearly invasive carcinomas and “in situ” trophoblast invasion

Blerta Dimo, Ioannis Ioannidis, Andreas Karameris, George Vilaras, Panagiota Tzoumakari, Aphrodite Nonni, Eystratios Patsouris, Andreas C. Lazaris

01.09.2012 | Original Paper | Ausgabe 3/2012

Unexpected effect of the monoclonal antibody Panitumumab on human cancer cells with different KRAS status

Nina Tiemann, Guido Hildebrandt, Katrin Manda

01.09.2012 | Original Paper | Ausgabe 3/2012

Compensatory and non-compensatory effects on protein expression following BCL-2 suppression by antisense oligonucleotides

Marvin Rubenstein, Courtney M. P. Hollowell, Patrick Guinan

01.09.2012 | Original Paper | Ausgabe 3/2012

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial

Jean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, Pere Gascon, Carsten Bokemeyer, Heinz Ludwig, Jan Vermorken, Jason Legg, Beatriz Pujol, Ken Bridges

01.09.2012 | Case Report | Ausgabe 3/2012

T-cell receptor gene rearrangement in Epstein–Barr virus infectious mononucleosis

L. Marbello, M. Riva, S. Veronese, A. M. Nosari, E. Ravano, A. Colosimo, L. Paris, E. Morra

01.09.2012 | Original Paper | Ausgabe 3/2012

Heart fatty acid-binding protein may not be an early biomarker for anthracycline-induced cardiotoxicity in rabbits

Ren-chun Lai, Xu-dong Wang, Xu Zhang, Wen-qian Lin, Tie-hua Rong

01.09.2012 | Letter to the Editor | Ausgabe 3/2012

P53 protein profile by IHC may be helpful to define patient prognosis

Marjory Alana Marcello, Elaine Cristina Morari, Laura Sterian Ward

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise